Reprogramming Sugar Metabolism & GLP-1s at CRN Convergence ‘26
GLP-1s changed the conversation around weight management almost overnight. Millions of people now rely on them, and brands across the nutraceutical space are racing to position their products as the best fit for their customers’ GLP-1 journey.
We’re bringing our revolutionary research-backed solution to Convergence ’26 to share with you!
Catch Us at Innovation Exchange
Tuesday, October 6 | 2:30–5:30 PM
Our Director of Science, Ankit Rathi, Ph.D., takes the Innovation Exchange stage to present Reprogramming Sugar Metabolism: A GLP-1 Companion for Metabolic Health.
The session digs into one of the biggest challenges of the GLP-1 boom: what happens to nutrient intake, digestion and long-term metabolic support once appetite drops and the gut slows down.
Join Ankit as he shares insights into SlimSEB™, our clinically studied next-generation metabolic health ingredient designed to complement GLP-1 use and stand on its own for consumers pursuing independent weight management.*
Science Behind SlimSEB™
SlimSEB™ is a powerful blend of enzymes, probiotics and herbal extracts. It uses an exclusive novel enzymatic mechanism that converts dietary sucrose into slowly digesting glucans with fiber-like properties during digestion.
Sugar isn’t blocked or bound as it is with other products on the market. A portion of it is transformed into short- and long-chain fibers prior to absorption, thereby delivering similar benefits to fiber intake.*
Eleven Research Studies, Eight Clinicals
Multiple clinical trials show SlimSEB™’s support for cardiometabolic health, healthy blood sugar and use alongside or after common weight loss products.*
Cardiometabolic Health
In one clinical trial of 84 participants over 87 days, results included:
- 8 lb weight loss*
- 6 cm decrease in waist circumference*
- 29-point reduction in HbA1c*
- 9% drop in total cholesterol*
Results from clinical trials showed:
- 9% decrease in post-meal glucose AUC (area under the curve)*
- 36 mg/dL reduction in blood glucose*
A 60-day clinical trial with 30 participants demonstrated:
- Greater reductions in body fat, BMI & waist circumference than on GLP-1s alone*
- Up to 27% reduction in abdominal pain, constipation & indigestion*
- Statistically significant gains in bodily pain, social functioning, energy & vitality scores*
- No reported adverse effects*
Support Across the GLP-1 Journey
SlimSEB™ isn’t a one-trick ingredient. It provides support across the entire GLP-1 arc:
- Adjunct | Enhance weight & metabolic outcomes during GLP-1 use while easing GI and bodily discomfort*
- Standalone | Support weight management & metabolic health for consumers who skip GLP-1s altogether*
- Post-GLP-1 | Help preserve metabolic & weight outcomes after discontinuation*
No other ingredient on the market works quite this way, and that’s exactly why we’re bringing it to the Innovation Exchange stage.
Celebrating Vic Rathi
A Trailblazer Award Nominee
Science doesn’t happen in a vacuum, and neither does innovation. We’re thrilled to share that our founder, Vic Rathi, has been nominated for the CRN and Radicle Science Annette Dickinson Trailblazer Award.Vic has spent more than 40 years turning complex enzymology into clinically validated ingredients trusted by brands and formulators worldwide. He has overseen the completion of:
- 71+ studies, 51 published
- 17 registered patents
- 9 GRAS dossiers
- 900+ custom enzyme and probiotic formulations
Known by some as the “Godfather of Enzymes,” Vic has a knack for spotting clinical potential in enzymes and probiotics. Colleagues consistently describe conversations with him as a masterclass in formulation strategy.
A family history of diabetes drives Vic’s mission to advance metabolic health science, and ingredients like SlimSEB™ reflect that mission in action. He doesn’t just formulate products. He reframes what enzymes and probiotics can do.
Attend our Presentation at Convergence ‘26
CRN’s Convergence ‘26 brings the industry’s sharpest minds together, and we’re showing up with real clinical data, a breakthrough mechanism and a founder whose four decades of work continue to shape the nutraceutical space.
Let’s connect at the conference! And be sure to catch our Innovation Exchange session, Reprogramming Sugar Metabolism: A GLP-1 Companion for Metabolic Health, on October 6, 2:30 – 5:30 PM, and help us celebrate Vic’s well-deserved nomination.
Science-backed ingredients start conversations. Let’s have one at Convergence ‘26.
